Showing results (501-510 of 584) with videos related to
Sort By:
Pageof 59
Nature Communications|December 13, 2025
Immunological and transcriptomic profile of chimeric live-attenuated Zika vaccine linked to protection in non-human primatesJi Ma, Bert Malengier-Devlies, Babs E Verstrepen, et al.Antimicrobial Agents and Chemotherapy|July 13, 2011
Mechanistic characterization of GS-9190 (Tegobuvir), a novel nonnucleoside inhibitor of hepatitis C virus NS5B polymeraseI-Hung Shih, Inge Vliegen, Betty Peng, et al.European Journal of Medicinal Chemistry|November 15, 2025
2-amido-3-aryl-4-methyl-thiazole derivatives as broad-spectrum anti-rhinoviral agentsSileshi Abera Ayele, Hye Lim Lee, Céline Sablon, et al.Science Advances|October 3, 2025
1'-Cyanocytidine-5'-isobutyryl is a potent SARS-CoV-2 inhibitor in culture and infected Syrian hamstersFranck Amblard, Mahesh Kasthuri, Julia C LeCher, et al.Nature Communications|October 30, 2021
Clinical practices underlie COVID-19 patient respiratory microbiome composition and its interactions with the hostVerónica Lloréns-Rico, Ann C Gregory, Johan Van Weyenbergh, et al.Antiviral Research|February 24, 2024
An in vivo duck hepatitis B virus model recapitulates key aspects of nucleic acid polymer treatment outcomes in chronic hepatitis B patientsYannick Debing, Hannah Vanrusselt, Lars Degrauwe, et al.Antiviral Research|July 5, 2025
Meeting report: 38th international conference on antiviral research in Las Vegas, United States of America, March 17-21, 2025Robert Jordan, Nancie M Archin, Valeria Cagno, et al.Antimicrobial Agents and Chemotherapy|July 31, 2013
A novel, broad-spectrum inhibitor of enterovirus replication that targets host cell factor phosphatidylinositol 4-kinase IIIβHilde M van der Schaar, Pieter Leyssen, Hendrik J Thibaut, et al.Microbiology Spectrum|June 7, 2022
A High-Throughput Yellow Fever Neutralization AssayMadina Rasulova, Thomas Vercruysse, Jasmine Paulissen, et al.Journal of Virology|December 15, 2005
A novel, highly selective inhibitor of pestivirus replication that targets the viral RNA-dependent RNA polymeraseJan Paeshuyse, Pieter Leyssen, Eric Mabery, et al.Pageof 59